{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T14:39:57Z","timestamp":1795185597546,"version":"4.10.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12905-018-0607-z","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T21:30:00Z","timestamp":1529011800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5518-1342","authenticated-orcid":false,"given":"Adane","family":"Bitew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshiwork","family":"Abebaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"607_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0889-8545(03)00083-4","volume":"30","author":"P Nyirjesy","year":"2003","unstructured":"Nyirjesy P, Sobel JD. Vulvovaginal candidiasis. Obstet Gynecol Clin N Am. 2003;30:671\u201384.","journal-title":"Obstet Gynecol Clin N Am"},{"key":"607_CR2","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jama.291.11.1368","volume":"291","author":"MR Anderson","year":"2004","unstructured":"Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291:1368\u201379.","journal-title":"JAMA"},{"key":"607_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejogrb.2008.12.020","volume":"144","author":"A Ahmad","year":"2009","unstructured":"Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009;144:68\u201371.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"607_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/1040841X.2011.576332","volume":"37","author":"M Ilkit","year":"2011","unstructured":"Ilkit M, Guzel AB. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Crit Rev Microbiol. 2011;37:250\u201361.","journal-title":"Crit Rev Microbiol"},{"key":"607_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00003081-199303000-00021","volume":"36","author":"JD Sobel","year":"1993","unstructured":"Sobel JD. Candida vulvovaginitis. Clin Obstet Gynecol. 1993;36:153.","journal-title":"Clin Obstet Gynecol"},{"key":"607_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1439-0507.2010.01965.x","volume":"54","author":"I Amouri","year":"2011","unstructured":"Amouri I, Sellami H, Borji N, Abbes S, Sellami A, Cheikhrouhou F, et al. Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia. Mycoses. 2011;54:499\u2013505.","journal-title":"Mycoses"},{"key":"607_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1099\/jmm.0.043992-0","volume":"61","author":"I Amouri","year":"2012","unstructured":"Amouri I, Sellami H, Abbes S, Hadrich I, Mahfoudh N, Makni H, et al. Microsatellite analysis of Candida isolates from recurrent vulvovaginal candidiasis. J Med Microb. 2012;61:1091\u20136.","journal-title":"J Med Microb"},{"issue":"RR12","key":"607_CR8","first-page":"1","volume":"59","author":"CDC","year":"2010","unstructured":"CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR. 2010;59(RR12):1\u2013110.","journal-title":"MMWR"},{"key":"607_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1556\/EUJMI-D-14-00027","volume":"4","author":"OA Olowe","year":"2014","unstructured":"Olowe OA, Makanjuola OB, Olowe R, Adekanle DA. Prevalence of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis among pregnant women receiving antenatal care in Southwestern Nigeria. Eur J Microbiol Immunol. 2014;4:193\u20137.","journal-title":"Eur J Microbiol Immunol"},{"key":"607_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.ajog.2003.11.027","volume":"190","author":"DA Patel","year":"2004","unstructured":"Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obst Gynecol. 2004;190:644\u201353.","journal-title":"Am J Obst Gynecol"},{"key":"607_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","volume":"178","author":"JD Sobe","year":"1998","unstructured":"Sobe JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obst Gynecol. 1998;178:203\u201311.","journal-title":"Am J Obst Gynecol"},{"key":"607_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1471-0528.2002.00432.x","volume":"109","author":"GG Donder","year":"2002","unstructured":"Donder GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Inter J Obstet Gynaecol. 2002;109:34\u201343.","journal-title":"Inter J Obstet Gynaecol"},{"key":"607_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007435-200004000-00009","volume":"27","author":"B Foxman","year":"2000","unstructured":"Foxman B, Barlow R, d'Arcy H, Gillepsie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000;27:230\u20135.","journal-title":"Sex Transm Dis"},{"key":"607_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1610-0387.2006.05935.x","volume":"4","author":"M Schaller","year":"2006","unstructured":"Schaller M. Candida albicans-interactions with the mucosa and the immune system. J Dtsch Dermatol Ges. 2006;4:328\u201336.","journal-title":"J Dtsch Dermatol Ges"},{"key":"607_CR15","doi-asserted-by":"publisher","first-page":"S 21","DOI":"10.1016\/S0020-7292(00)00350-7","volume":"71","author":"J Ferrer","year":"2000","unstructured":"Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynecol Obstet. 2000;71:S 21\u20137.","journal-title":"Int J Gynecol Obstet"},{"key":"607_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1086\/317936","volume":"183","author":"JD Sobel","year":"2001","unstructured":"Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, et al. The evolution of Candida spp. and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis. 2001;183:286\u201393.","journal-title":"J Infect Dis"},{"key":"607_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1258\/095646206776253435","volume":"17","author":"A Beltrame","year":"2006","unstructured":"Beltrame A, Matteelli A, Cristina A, Carvalho C, Saleri N, Casalini C, et al. Vaginal colonization with Candida spp. in human immunodeficiency virus-infected women: a cohort study. Int J STD AIDS. 2006;17:260\u20136.","journal-title":"Int J STD AIDS"},{"key":"607_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1590\/S1517-83822014005000018","volume":"44","author":"MSC Melhem","year":"2013","unstructured":"Melhem MSC, Bertoletti A, Lucca HRL, Silva RBO, Meneghin FA, Szeszs MW. Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species. Braz J Microbiol. 2013;44:1257\u201366.","journal-title":"Braz J Microbiol"},{"key":"607_CR19","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1128\/JCM.42.4.1542-1546.2004","volume":"42","author":"JL Donay","year":"2004","unstructured":"Donay JL, Mathieu D, Fernandes P, Pregermain C, Bruel P, Wargnier A, et al. Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory. J Clin Microbiol. 2004;42:1542\u20136.","journal-title":"J Clin Microbiol"},{"key":"607_CR20","first-page":"4","volume-title":"Provisional Guidelines on Standard International Age Classifications: Statistical Papers, Series M","author":"WHO","year":"1982","unstructured":"WHO. Provisional Guidelines on Standard International Age Classifications: Statistical Papers, Series M, vol. 74. New York: United Nations; 1982. p. 4\u201311."},{"key":"607_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/sti.2003.004192","volume":"80","author":"E ERylander","year":"2004","unstructured":"ERylander E, Berglund A-L, Krassny C, Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect. 2004;80:54\u20137.","journal-title":"Sex Transm Infect"},{"key":"607_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3122\/jabfm.2008.04.070169","volume":"21","author":"J Xu","year":"2008","unstructured":"Xu J, Schwartz K, Bartoces M, Joseph M, Severson R, Sobel JD. Effect of antibiotics on vulvovaginal candidiasis: a Metro Net study. J Am Board Fam Med. 2008;21:261\u20138.","journal-title":"J Am Board Fam Med"},{"key":"607_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0010-7824(95)00079-P","volume":"51","author":"A Spinillo","year":"1995","unstructured":"Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vulvovaginal candidiasis. Contraception. 1995;51:293\u20137.","journal-title":"Contraception"},{"key":"607_CR24","doi-asserted-by":"publisher","first-page":"859071","DOI":"10.1155\/2012\/859071","volume":"2012","author":"SD Rathod","year":"2012","unstructured":"Rathod SD, Klausner JD, Krupp K, Reingold AL, Adhivanan P. Epidemiologic Features of Vulvovaginal Candidiasis among Reproductive-Age Women in India. Infect Dis ObstGynecol. 2012;2012:859071, 8 pages. https:\/\/doi.org\/10.1155\/2012\/859071 .","journal-title":"Infect Dis ObstGynecol"},{"key":"607_CR25","first-page":"108","volume":"4","author":"K Yadav","year":"2016","unstructured":"Yadav K, Prakash S. Prevalence of vulvovaginal candidiasis in pregnancy. Glob J Med Med Sci. 2016;4:108\u201316.","journal-title":"Glob J Med Med Sci"},{"key":"607_CR26","first-page":"343","volume":"37","author":"A Spinillo","year":"1992","unstructured":"Spinillo A, Carrata L, Pizzolia G. Reccurent volvovaginal candidiasis: result of a cohort study of sexually transmitted transmission and intestinal reservoir. J Repord Med. 1992;37:343\u20137.","journal-title":"J Repord Med"},{"key":"607_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2298\/VSP1010819J","volume":"67","author":"S Jankovi\u0107","year":"2010","unstructured":"Jankovi\u0107 S, Bojovi\u0107 D, Vukadinovi\u0107 D, Daglar E, Jankovi\u0107 M, Laudanovi\u0107 D, et al. Risk factors for recurrent vulvovaginal candidiasis. Vojnosanit Pregl. 2010;67:819\u201324.","journal-title":"Vojnosanit Pregl"},{"issue":"2","key":"607_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10647440400025629","volume":"13","author":"JP Ttrama","year":"2005","unstructured":"Ttrama JP, Adelson ME, Raphaelli I, Stemmer SM, Mmordechai E. Detection of Candida species in vaginal samples in a clinical laboratory setting. Infect Dis Obstet Gynecol. 2005;13(2):63\u20137.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"607_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1067\/mob.2002.125897","volume":"187","author":"TGM Bauters","year":"2002","unstructured":"Bauters TGM, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol. 2002;187:569\u201374.","journal-title":"Am J Obstet Gynecol"},{"key":"607_CR30","first-page":"304","volume":"12","author":"MMA Haleim","year":"2015","unstructured":"Haleim MMA, El-Feky EAM, Sayed A, Ismail DK, Sayed AM, Abdella RMA. Provence of non albicans species associated with vulvovaginal candidiasis in Egyptian women. Int J Adv Int Health Sci. 2015;12:304\u201313.","journal-title":"Int J Adv Int Health Sci"},{"key":"607_CR31","doi-asserted-by":"publisher","first-page":"e15992","DOI":"10.5812\/jjm .8(4)2015.1599","volume":"8","author":"MT Hedayati","year":"2015","unstructured":"Hedayati MT, Taheri Z, Galinimorhadam T, Aghili SR, Cherati JY, Mosayebi E. Isolation of different species of candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur J Microbial. 2015;8:e15992. https:\/\/doi.org\/10.5812\/jjm%20.8(4)2015.1599 .","journal-title":"Jundishapur J Microbial"},{"key":"607_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0002-9378(95)90347-X","volume":"173","author":"P Nyirjesy","year":"1995","unstructured":"Nyirjesy P, Seeney SM, Grody MHT, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol. 1995;173:820\u20133.","journal-title":"Am J Obstet Gynecol"},{"key":"607_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa033114","volume":"351","author":"JD Sobel","year":"2004","unstructured":"Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TH, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351:876\u201383.","journal-title":"N Engl J Med"},{"issue":"8","key":"607_CR34","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.5812\/jjm.12804.","volume":"10","author":"S Hasanvand","year":"2017","unstructured":"Hasanvand S, Qomi HA, Kord M, Didehdar M. Molecular epidemiology and in vitro antifungal susceptibility of Candida isolates from women with vulvovaginal candidiasis in northern cities of Khuzestan Province. Iran Jundishapur J Microbiol. 2017;10(8):12804. https:\/\/doi.org\/10.5812\/jjm.12804.","journal-title":"Iran Jundishapur J Microbiol"},{"key":"607_CR35","volume-title":"Federal HIV\/AIDS Prevention and Control","author":"Guidelines for Management of Opportunistic Infections and Antiretroviral Treatment in Adolescents and Adults in Ethiopia","year":"2007","unstructured":"Guidelines for Management of Opportunistic Infections and Antiretroviral Treatment in Adolescents and Adults in Ethiopia. Federal HIV\/AIDS Prevention and Control. Addis Ababa: Office Federal Ministry of Health; 2007."},{"key":"607_CR36","volume-title":"Standard Treatment Guideline","author":"Ministry of Health","year":"2004","unstructured":"Ministry of Health. Standard Treatment Guideline. Addis Ababa: Drug Administration and Control Authority, Ministry of Health; 2004."},{"key":"607_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2165\/00003495-199754050-00002","volume":"54","author":"BD Alexander","year":"1997","unstructured":"Alexander BD, Perfect JR. Antifungal resistance trends towards the year 2000: implications for therapy and new approaches. Drugs. 1997;54:657\u201378.","journal-title":"Drugs"},{"key":"607_CR38","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1128\/AAC.45.7.2129-2133.2001","volume":"45","author":"A Safdar","year":"2001","unstructured":"Safdar A, Chaturvedi V, Cross EW, Park S, Bernard EM, Armstrong D, et al. Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother. 2001;45:2129\u201333.","journal-title":"Antimicrob Agents Chemother"},{"key":"607_CR39","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1128\/JCM.43.5.2155-2162.2005","volume":"43","author":"SS Richter","year":"2005","unstructured":"Richter SS, Rudolph P, Galask RP, Shawn A, Messer SA, Richard J, et al. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43:2155\u201362.","journal-title":"J Clin Microbiol"},{"key":"607_CR40","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1128\/JCM.02363-09","volume":"48","author":"GM Lyon","year":"2010","unstructured":"Lyon GM, Karatela S, Sunay S, Adiri Y. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol. 2010;48:1270\u20135.","journal-title":"J Clin Microbiol"},{"key":"607_CR41","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1128\/JCM.00409-07","volume":"45","author":"MD Pfaller","year":"2007","unstructured":"Pfaller MD, Diekema D, Gibbs V, Newell J, Meis I, Gould W, et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI 30 standardized disk diffusion testing. J Clin Microbiol. 2007;45:1735\u201345.","journal-title":"J Clin Microbiol"},{"key":"607_CR42","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","volume":"40","author":"DJ Diekema","year":"2002","unstructured":"Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol. 2002;40:1298\u2013302.","journal-title":"J Clin Microbiol"},{"key":"607_CR43","first-page":"501","volume-title":"Principles and practice of infectious diseases","author":"J Rex","year":"2005","unstructured":"Rex J, Stevens D. Systemic antifungal agents. In: Mandell G, Bennett J, Dolin R, editors. Principles and practice of infectious diseases, vol. 1. 6th ed. Philadelphia: Elsevier; 2005. p. 501\u201311.","edition":"6"},{"key":"607_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1086\/520980","volume":"45","author":"PC Pappas","year":"2007","unstructured":"Pappas PC, Rotstein R, Betts M, Nucci D, Talwar J, De Waele J, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007;45:883\u201393.","journal-title":"Clin Infect Dis"},{"key":"607_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10096-003-1014-3","volume":"22","author":"LA Ostrosky-Zeichne","year":"2003","unstructured":"Ostrosky-Zeichne LA, Lashof MO, Kullberg BJ, Rex JH. Voriconazole salvage treatment of invasive candidiasis. Eur J Clin Microbiol Infect Dis. 2003;22:651\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"607_CR46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3410\/B2-66","volume":"2","author":"CA Munro","year":"2010","unstructured":"Munro CA. Fungal echinocandin resistance. F1000 Biol Rep. 2010;2:66.","journal-title":"F1000 Biol Rep"},{"key":"607_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"ZA Kanafani","year":"2008","unstructured":"Kanafani ZA, Perfect JR. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infec Dis. 2008;46:120\u20138.","journal-title":"Clin Infec Dis"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-018-0607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-018-0607-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-018-0607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T12:21:01Z","timestamp":1604406061000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-018-0607-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["607"],"URL":"https:\/\/doi.org\/10.1186\/s12905-018-0607-z","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YA, is a medical laboratory technologist with Msc degree in microbiology, she has been working as a medical laboratory technologist for Fitche Hospital for many years.AB is an associate professor of microbiology and consultant health science specialist with a PhD degree. He has been working as a researcher and instructor offering courses to graduate students in the college of health sciences, Addis Ababa University for more than 24\u00a0years. He has published many original articles in peer-reviewed international journal.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The study was conducted after it was ethically reviewed and approved by the Ethical Review board of the Department of Medical Laboratory Sciences (DRERC), School of Health Sciences, and Addis Ababa University. Written consents were also obtained from participants. Assent form was completed and signed by family member and\/or adult guardian for participants under the age of 18\u00a0years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"94"}}